The Division of Hematology and Oncology conducts research and treats all types of adult cancers including solid tumor cancers and hematological (blood) disorders, as well as coagulation disorders and non-cancerous blood diseases. With over 80 faculty members representing a broad range of professional training and expertise, our dedicated team of professionals is committed to cancer care through research to better understand and treat cancers; state-of-the-art patient care and personalized cancer therapy; clinical trials, including Phase I drug development with subsequent Phase II and Phase III testing; training future cancer doctors and researchers; and cancer chemotherapy, pharmacology, and biological therapy with an emphasis on solid tumors.